EUVIMEDEUVIMED entdecken
Open Access

Analysis Populations in Anti-Infective Clinical Trials: Whom to Analyze?

Scott Evans, Daniel B Rubin, John H Powers, Dean Follmann

Statistical Communications in Infectious Diseases · 2018

DOI: 10.1515/scid-2017-0002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Statistical Communications in Infectious Diseases, 2018. Verfasst von Scott Evans und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics, Milken Institute School of Public Health of The George Washington University, Innovations in Design, Ed…. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: CCR NIH HHS, NCI NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Investigators can choose to analyze different patient populations in clinical trials. The different analysis populations answer different types of research questions, estimate different quantities, and evaluate the robustness of the trial results. Various analysis populations have different strengths and weaknesses depending on the type of question being addressed and the potential for bias from the selection of various groups of trial participants. We discuss analysis populations in the context of anti-infective clinical trials.

Schlagwörter

Stichwörter der Autor:innen

analysis populationsanti-infectivesclinical trialsintent-to-treat

Autor:innen und Institutionen

  • Department of Epidemiology and Biostatistics, Milken Institute School of Public Health of The George Washington University, Innovations in Design, Education, and Analysis (IDEA) Committee ,The Biostatistics Center, 6610…
  • Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.
  • Clinical Research Directorate/Clinical Monitoring Research Program,Leidos Biomedical Research, Inc., NCI Campus at Frederick, Frederick, MD 21702, USA.
  • George Washington University School of Medicine, Washington DC, USA.
  • National Institute of Allergy and Infectious Diseases of the National Institutes of Health, Rockville, United States of America.

Förderung

  • CCR NIH HHS
  • NCI NIH HHS
  • NIAID NIH HHS

Zitieren

APA

Evans, S., Rubin, D. B., Powers, J. H., & Follmann, D. (2018). Analysis Populations in Anti-Infective Clinical Trials: Whom to Analyze?. Statistical Communications in Infectious Diseases. https://doi.org/10.1515/scid-2017-0002

Vancouver

Evans S, Rubin DB, Powers JH, Follmann D. Analysis Populations in Anti-Infective Clinical Trials: Whom to Analyze?. Statistical Communications in Infectious Diseases. 2018. doi:10.1515/scid-2017-0002

BibTeX
@article{Evans2018,
  author = {Evans, Scott and Rubin, Daniel B and Powers, John H and Follmann, Dean},
  title = {Analysis Populations in Anti-Infective Clinical Trials: Whom to Analyze?},
  journal = {Statistical Communications in Infectious Diseases},
  year = {2018},
  doi = {10.1515/scid-2017-0002}
}
Kostenlos starten →